CoChat

Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba

The Cuba IPV Study Collaborative Group · 2007 · New England Journal of Medicine

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Abstract

BACKGROUND: After poliomyelitis has been eradicated, access to live polioviruses will be highly restricted and the use of oral poliovirus vaccine (OPV) will probably be discontinued. Countries using OPV must decide whether to switch to inactivated poliovirus vaccine (IPV) or stop polio vaccination. Because data on the immunogenicity of IPV in tropical developing countries are limited, we conducted a randomized, controlled trial of IPV in Cuba. METHODS: The study population consisted of healthy infants born in Havana. A total of 166 infants were randomly assigned to two groups. Group A received a combination of the diphtheria-pertussis-tetanus (DPT) vaccine, the Haemophilus influenzae type b (Hib) vaccine, and IPV (DPT-Hib-IPV) at 6, 10, and 14 weeks of age. Group B, the control group, received a combination of the DPT vaccine and the Hib vaccine at 6, 10, and 14 weeks of age. Another group (group C, 100 infants), which did not undergo randomization at the same time as groups A and B, received the DPT-Hib-IPV combination at 8 and 16 weeks of age. Serum samples were collected before vaccination and at least 4 weeks after the last dose. Stool samples were obtained before and 7 days after challenge with OPV. RESULTS: The seroconversion rates in group A were 94%, 83%, and 100% for types 1, 2, and 3 poliovirus, respectively. There were no seroconversions in group B. The seroconversion rates in group C were 90%, 89%, and 90% for poliovirus types 1, 2, and 3, respectively. For groups A, B, and C, the virus isolation rates after challenge with OPV were 94%, 91%, and 97%, respectively, and the mean log10 viral titers of any serotype were 3.46, 3.89, and 3.37, respectively. There was one major adverse event, an episode of hypotonia. CONCLUSIONS: Vaccination with two or three doses of IPV resulted in a rate of seroconversion of at least 90%, except for seroconversion against type 2. The viral titer of OPV shed in the stool after OPV challenge was reduced in both groups receiving IPV. (ClinicalTrials.gov number, NCT00260312 [ClinicalTrials.gov].).

Overview

Integrity signals

Registry

Crossref · 10.1056/nejmoa054960

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 22 references

Research works printed but not linked: 11

  1. 2004, Wkly Epidemiol Rec, 79, 349
  2. 2004, Wkly Epidemiol Rec, 79, 401
  3. Sutter RW, 2004, Bull World Health Organ, 82, 31
  4. 2003, Wkly Epidemiol Rec, 78, 241
  5. 1996, Bull World Health Organ, 74, 253
  6. Mas Lago P, 1999, Bull World Health Organ, 77, 681
  7. Kok PW, 1992, Bull World Health Organ, 70, 93
  8. Krishnan R, 1983, Bull World Health Organ, 61, 689
  9. Simoes EA, 1985, Am J Dis Child, 139, 977
  10. Ghendon YUZ, 1961, Acta Virol, 5, 265
  11. Marine WM, 1962, Am J Hyg, 76, 173

Cited by

See all 90

Metadata

Authors
The Cuba IPV Study Collaborative Group
Corresponding author
The Cuba IPV Study Collaborative Group
Venue
New England Journal of Medicine
Published
2007-04-12
Volume
356
Issue
15
Pages
1536-1544
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2335890187
Cited by
90
References
22
Citations by year
2024: 1 · 2023: 7 · 2021: 1 · 2020: 2 · 2019: 5 · 2018: 8 · 2017: 7 · 2016: 3 · 2015: 11 · 2014: 4 · 2013: 7 · 2012: 9
FWCI
4.44
Type
journal article
Language
en
Open access
closed
Locations
  • New England Journal of Medicine (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
  • Social Sciences › Health › Vaccine Coverage and Hesitancy
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Keywords
inactivated poliovirus vaccine, infants, poliovirus type 2, Cuba, tropical developing countries, vaccine adverse events, hypotonia, viral shedding in stool, polio eradication
MeSH terms
Antibodies, Viral, Cuba, Feces, Humans, Infant, Infant, Newborn, Poliomyelitis, Poliovirus Vaccine, Inactivated, Polysaccharides, Bacterial, Diphtheria-Tetanus-Pertussis Vaccine, Bacterial Capsules, Vaccines, Combined, Poliovirus, Haemophilus Vaccines

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba. https://app.cochat.ai/papers/10.1056/nejmoa054960
The paper
The Cuba IPV Study Collaborative Group. (2007). Randomized, Placebo-Controlled Trial of Inactivated Poliovirus Vaccine in Cuba. New England Journal of Medicine. https://doi.org/10.1056/nejmoa054960

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.